XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]        
Revenue, net $ 19,193 $ 7,391 $ 51,116 $ 169,580
Cost of revenue (11,515) (5,709) (30,669) (24,829)
Gross profit 7,678 1,682 20,447 144,751
Operating expenses:        
Research and development expenses 59 26,443 76,340 260,599
Sales and marketing expenses 0 5,141 3,428 353,049
General and administrative expenses 36,787 113,233 219,345 408,630
Total operating expenses 36,846 144,817 299,113 1,022,278
Loss from operation (29,168) (143,135) (278,666) (877,527)
Other income (expense):        
Government subsidy 0 927 0 9,185
Interest income 1 1 5 1
Interest expense (100,681) (43,750) (302,019) (90,903)
Loss on impairment of inventories 0 0 0 (750)
Total other expense, net (100,680) (42,822) (302,014) (82,467)
LOSS BEFORE INCOME TAXES (129,848) (185,957) (580,680) (959,994)
Income tax expense 0 0 0 0
NET LOSS (129,848) (185,957) (580,680) (959,994)
Other comprehensive loss:        
– Foreign currency adjustment loss (5,865) (10,210) (10,544) (3,266)
COMPREHENSIVE LOSS $ (135,713) $ (196,167) $ (591,224) $ (963,260)
Net loss per share – Basic and Diluted*        
– Basic $ (0.00) $ (0.00) $ (0.00) $ (0.00)
– Diluted $ (0.00) $ (0.00) $ (0.00) $ (0.00)
Weighted average outstanding shares        
– Basic 5,484,167,213 5,484,167,213 5,484,167,213 5,248,165,102
– Diluted 8,484,167,213 8,484,167,213 8,484,167,213 8,248,165,102